Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06970028

Somatosensory Phenotyping of ADPKD

Somatosensory Phenotyping of Patients With ADPKD Using Quantitative Sensory Testing and Questionnaires

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

Over 60% of patients with ADPKD suffer from pain, mostly in the abdomen, flank and back, often leading to the diagnosis. It is challenging to manage and cure the pain; approximately 39% of patients are not satisfied with their pain treatment, since the pain prevents them from doing various activities, affecting their quality of life. Pain can be present before enlargement of the kidneys, the source of the pain is often unknown and common analgesics are insufficient to manage the pain or cannot be taken due to renal impairment. By further investigating and characterizing the pain phenotype of the ADPKD population, pain management might be improved and alternative therapeutic approaches might be developed. In this clinical study, pain will be assessed in patients with ADPKD using Quantitative Sensory Testing (QST) on the dominant hand and the lower back, together with four questionnaires regarding pain and quality of life. These results will be compared with the somatosensory profile of matched healthy volunteers.

Conditions

Interventions

TypeNameDescription
OTHERQuantitative Sensory TestingWe will perform QST on the dominant hand and lower back.
OTHERQuestionnaires regarding pain and quality of lifeQuestionnaires will be filled out by patients with ADPKD to evaluate pain and quality of life.

Timeline

Start date
2025-09-09
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-05-14
Last updated
2025-11-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06970028. Inclusion in this directory is not an endorsement.